Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed250%
enrolling_by_invitation125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completednot_applicable

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease

NCT05862649
recruiting

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

NCT05476523
enrolling_by_invitationnot_applicable

Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely

NCT06597071
completednot_applicable

A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

NCT05795023

Clinical Trials (4)

Showing 4 of 4 trials
NCT05862649Not Applicable

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease

Completed
NCT05476523

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Recruiting
NCT06597071Not Applicable

Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely

Enrolling By Invitation
NCT05795023Not Applicable

A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4